Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3receptor inverse agonist/antagonist compared with Modafinil-Reference-Cited by-同舟云学术

Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3receptor inverse agonist/antagonist compared with Modafinil

Published:2013-05-16 Issue:3 Volume:169 Page:632-644
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Uguen M¹,Perrin D¹,Belliard S¹,Ligneau X¹,Beardsley PM²,Lecomte JM¹,Schwartz JC¹

Affiliation:

1. Bioprojet-Biotech; Saint Grégoire Cedex; France

2. Department of Pharmacology & Toxicology; Virginia Commonwealth University; Richmond; VA; USA

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12149/fullpdf

Reference60 articles.

1. Dopamine transporter-related effects of modafinil in rhesus monkeys;Andersen;Psychopharmacology (Berlin),2010

2. Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist;Barbier;Br J Pharmacol,2004

3. The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys;Beardsley;J Pharmacol Exp Ther,1990

4. Modafinil reinstates a cocaine conditioned place preference following extinction in rats;Bernardi;Behav Brain Res,2009

5. The H3 antagonist thioperamide reveals conditioned preference for a context associated with an inactive small dose of cocaine in C57BL/6J mice;Brabant;Behav Brain Res,2005

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic challenges and burden of idiopathic hypersomnia: a systematic literature review;Sleep Advances;2024-01-01

2. Pitolisant: Pediatric First Approval;Pediatric Drugs;2023-05-26

3. Clinical study of “Jiaotai Pill” combined with head massage with 5-tone rhythm on insomnia patients of heart-kidney disharmony type;Medicine;2023-01-06

4. An Update on the Misuse and Abuse Potential of Pharmacological Treatments for Central Disorders of Hypersomnolence;Current Sleep Medicine Reports;2022-09-19

5. Convergent cross-species pro-cognitive effects of RGH-235, a new potent and selective histamine H3 receptor antagonist/inverse agonist;European Journal of Pharmacology;2022-02